Market Overview

Why Atossa Therapeutics Stock Is Trading Higher Today


Atossa Therapeutics (NASDAQ: ATOS) shares are trading higher on Thursday after Ascendiant Capital initiated coverage on the stock with a Buy rating and a price target of $7 per share.

Atossa Therapeutics is a clinical-stage pharmaceutical company operating in the US. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions.

Atossa Therapeutics shares were up 9.78% at $2.47 at the time of publication on Thursday. The stock has a 52-week high of $5.08 and a 52-week low of 76 cents.

Latest Ratings for ATOS

Sep 2020Ascendiant CapitalInitiates Coverage OnBuy
Dec 2019Maxim GroupUpgradesHoldBuy
Jan 2018Maxim GroupInitiates Coverage OnBuy

View More Analyst Ratings for ATOS
View the Latest Analyst Ratings


Related Articles (ATOS)

View Comments and Join the Discussion!

Posted-In: why it's movingPenny Stocks Initiation Analyst Ratings

Latest Ratings

INTCJP MorganMaintains70.0
STMCanaccord GenuityMaintains47.0
ELDeutsche BankMaintains248.0
UAADeutsche BankMaintains13.0
INTCDeutsche BankMaintains55.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at